Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews


Print Page Follow BioNews on Twitter BioNews RSS feed

Like the Progress Educational Trust on Facebook






Genetic screens detect 'hypermutated' prostate cancers

03 October 2011

By Sarah Guy

Appeared in BioNews 627

Sequencing tissue samples from patients with deadly forms of prostate cancer has revealed previously undefined, drug-resistant tumour types that are ten times more mutated than other varieties, report researchers. The findings could help scientists develop screening methods and treatments specific to these 'hypermutated' forms of the disease.

'We don't know the cause of these hypermutated tumours, but the frequency of the mutations suggests these tumours might evolve very rapidly to develop resistance to therapies', said Dr Peter Nelson from the Fred Hutchinson Cancer Research Center in Seattle, USA.

For the study, published in the journal Proceedings of the National Academy of Sciences, the researchers sequenced the exomes (the parts of the DNA that code for proteins) of 23 prostate cancers grown in immunodeficient mice, of which 16 had originated as lethal metastatic cancers, and three as high-grade forms of the disease in humans.

The team found unexpected results; three of the prostate cancer genomes displayed much higher mutation frequencies than tumours derived from other tumour samples – in the region of 2,000 to 4,000 novel coding variants per exome. 'That was very surprising and unusual', said Dr Nelson.

After comparison of treatment-resistant and non-resistant versions of these tumours, the researchers saw that the mutations were in the Wnt pathway. This is a network of proteins known for their role in cancer development and progress, which could help future research into why some prostate cancers are resistant to drugs.

Co-author Dr Jay Shendure said: 'The mutations underlying the progression of prostate cancer to an advanced state have been understudied to date. Although further work is necessary, our hope is that identifying the genes in which these mutations occur will facilitate biological insights and the development of new therapeutic strategies'.

 

SOURCES & REFERENCES
PNAS | 26 September 2011
 
Genetic enginnering and biotechnology news | 27 September 2011
 
Daily Mail | 26 September 2011
 
Research finds hypermutated cancers
Press Association | 27 September 2011
 
Science Daily | 27 September 2011
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

13 May 2013 - by Daryl Ramai 
A genetic test released in the USA claims to be able to score the aggressiveness of prostate cancer before medical intervention, helping men with the condition decide if and when to start receiving treatment.... [Read More]
16 January 2012 - by Dr Linda Wijlaars 
A rare gene variant that could increase the risk of prostate cancer has been identified by researchers in the USA. Although the variant accounts for only a small fraction of all prostate cancers, the study found it was more common in men with an inherited form of the cancer and in those who are diagnosed before the age of 55... [Read More]
10 October 2011 - by Dr Rebecca Robey 
The winners of the Nobel Prize in Physiology or Medicine 2011 were announced on 3 October with an unusual twist – for the first time the accolade has been bestowed on someone posthumously. This is normally against the Nobel Assembly's rules, but Professor Ralph Steinman's untimely death on 30 September occurred after messages had been sent to him informing him of his success... [Read More]

22 August 2011 - by Sarah Guy 
US researchers have made a discovery that might help doctors distinguish between benign and more aggressive forms of prostate cancer. The team reports that a difference in the genetic make-up of prostate tumours could indicate which are likely to metastasize and spread through the body, and which will be slow-growing and non-fatal... [Read More]
01 August 2011 - by Dr Charlotte Maden 
Two new initiatives have been launched by Cancer Research UK, aiming to increase the understanding of prostate and oesophageal cancers which will speed up the development of personalised treatments for patients.... [Read More]
16 May 2011 - by Kimberley Bryon-Dodd 
Screening for breast and prostate cancer based on genetic risk factors as well as age could reduce the number of people screened without a significant reduction in the number of cancers detected, a new study suggests.... [Read More]
14 February 2011 - by Dr Lucy Freem 
US researchers have sequenced the genomes of several prostate tumours providing new information that may help doctors to identify aggressive forms of the cancer and prioritise treatment... [Read More]
28 September 2009 - by Dr Charlotte Maden 
Four genetic studies into prostate cancer have uncovered new genetic variations associated with the disease. The information may be used to provide a more reliable indication of the risk a man has of developing prostate cancer.... [Read More]

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions

 


 

- click here to enquire about using this story.

Printer Friendly Page

Published by the Progress Educational Trust

Advertise your products and services HERE - click for further details

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation

Good Fundraising Code

Find out more about the Progress Educational Trust by downloading our brochure HERE